Egetis Therapeutics (EGTX.ST) traded down -1.95 % during a 24 hours period ending at 04:48 PM Central Europe on Monday 26th. One Egetis Therapeutics stock can currently be bought for about SEK 9.28 on popular exchanges. Current supply of Egetis Therapeutics stocks is 464.7 mn. Egetis Therapeutics has a current market capitalization of SEK 4.2 bn and approximately SEK 13.8 mn worth of Egetis Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Egetis Therapeutics has traded 17.51 % up. Simple moving average of last 200 days is at SEK 6.33. The highest price of past 52 weeks was recorded at SEK 10.14 on 10/08/2026. 52 weeks low was at SEK 3.62 on 11/26/2025.

Here is how related stocks have performed in the past 24 hours:

  • Stendorren Fastigheter (STEF-B.ST) traded up 0.26 % and now trades at SEK 155.2. Current market capitalisation for Stendorren Fastigheter is SEK 5 bn. Current price/earnings ratio for Stendorren Fastigheter is 15.09.

  • Bhg (BHG.ST) traded up 15.1 % and now trades at SEK 24.72. Current market capitalisation for Bhg is SEK 4.5 bn. Bhg has a current price to earnings ratio of 50.9. Bygghemma Group AB reported its latest quarterly results at a financial conference in late October. The company announced a higher earnings per share than the same period a year earlier, surpassing analysts’ expectations. Revenue rose noticeably, outpacing last year’s figure. These figures suggest that the company’s financial performance has improved over the past year, reflecting a positive trend in profitability and sales growth. The results were communicated to shareholders and market observers during the conference, reinforcing the company’s commitment to transparent reporting.

  • Goldsky (GSKR-SDB.ST) traded down -4.35 % and now trades at SEK 17.8. Current market capitalisation for Goldsky is SEK 4.7 bn.

  • Morrow Bank (MORROW.ST) traded down -0.66 % and now trades at SEK 15.28. Current market capitalisation for Morrow Bank is SEK 4.8 bn. Morrow Bank has a current price to earnings ratio of 14.4.

  • Bts (BTS-B.ST) traded up 1.09 % and now trades at SEK 233. Current market capitalisation for Bts is SEK 4.5 bn. Bts has a current price to earnings ratio of 47.33.

About Egetis Therapeutics

Egetis Therapeutics AB is a pharmaceutical drug development company operating in the health care sector with a focus on projects in late-stage development for the treatment of rare and niche diseases with significant unmet medical needs in the orphan drug segment.